Join the Plaquenil group to help and get support from people like you.
Plaquenil News
Hydroxychloroquine Safe, Effective Treatment for Anogenital Lichen Sclerosus
FRIDAY, July 26, 2024 – Hydroxychloroquine appears to be a safe and effective treatment option for anogenital lichen sclerosus that only has mild adverse effects, according to a study published...
Some Children Prescribed Nonrecommended Meds for COVID-19
MONDAY, May 13, 2024 – Despite national guidelines, a small proportion of children were prescribed ineffective and potentially harmful medications for acute COVID-19, according to a study published...
Study Identifies Factors Associated With Hydroxychloroquine Retinopathy
MONDAY, May 13, 2024 – Factors associated with an increased risk for hydroxychloroquine retinopathy have been identified and include female sex, older age, and chronic kidney disease stage 3 or...
FDA Medwatch Alert: Remdesivir by Gilead Sciences: FDA Warns of Newly Discovered Potential Drug Interaction That May Reduce Effectiveness of Treatment
ISSUE: FDA is warning health care providers that co-administration of remdesivir and chloroquine phosphate or hydroxychloroquine sulfate is not recommended as it may result in reduced antiviral...
FDA Medwatch Alert: Drug Safety Communication: Hydroxychloroquine or Chloroquine for COVID-19 - FDA Cautions Against Use Outside of the Hospital Setting or a Clinical Trial Due to Risk of Heart Rhythm Problems
ISSUE: FDA is concerned that hydroxychloroquine and chloroquine are being used inappropriately to treat non-hospitalized patients for coronavirus disease (COVID-19) or to prevent that disease. We ...
Chloroquine and Hydroxychloroquine Under Investigation for COVID-19
US to conduct clinical trials of chloroquine for COVID-19 Clinical trials of chloroquine and its less toxic metabolite, hydroxychloroquine, are ongoing or due to start in other countries. Both drugs...
Further information
Related condition support groups
Rheumatoid Arthritis, Systemic Lupus Erythematosus